Astellas Pharma and Tokyo Institute of Technology have announced a joint research agreement for drug discovery research leveraging Tokyo-Tech's TSUBAME2.0 supercomputer to discover candidates for the treatment of diseases caused by ...
Certara, a provider of drug discovery and development software and scientific consulting services, has released a new version of Phoenix, the PK/PD modeling software platform. All Phoenix tools are accessed within a single graphical user ...
Tags: Certara, Phoenix WinNonlin 6.3, PK/PD modeling software platform
PerkinElmer has integrated its electronic laboratory notebook (ELN) with Elsevier's Reaxys, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals and academic research. PerkinElmer Informatics ...
Tags: PerkinElmer, ELN, Elsevier's Reaxys
US based pharmaceutical company, Amgen has acquired KAI Pharmaceuticals. The acquisition, which was initially announced on 10 April 2012, includes KAI's main product KAI-4169, an agent being studied to treat secondary hyperparathyroidism ...
Corning Incorporated (NYSE: GLW) Senior Vice President and Corporate Controller Tony Tripeny will update investors at the Credit Suisse Annual Technology Conference in Scottsdale, Ariz., today (3p.m. MST) on the company's fourth-quarter ...
Tags: LCD glass, LCD televisions, consumer electronics devices, LCD TV
Evotec and Haplogen have signed a drug discovery partnership targeting viral infectious diseases. The drugs resulting from the partnership are expected to target a human protein that is vital for the spread of pathogenic viral ...
Tags: the human protein, targeting viral infectious diseases, Haplogen, Evotec
Full Spectrum Genetics and BioBlocks have signed an agreement to find new Small Molecule Therapeutics for protein-protein interactions As part of the agreement, Full Spectrum Genetics protein analysis and engineering platform, MapEng, and ...
Tags: Full Spectrum Genetics, BioBlocks, new small molecule therapeutics
BioFocus, the Galapagos' service division, and Ono Pharmaceutical have signed a new drug discovery agreement focusing on CNS disorders. BioFocus managing director and Galapagos Services SVP Dr. Chris Newton said, "This project plays to ...
BioFocus and Activiomics have formed a partnership,which will enable BioFocus to offer its customers Activiomics' proteomics services to improve identification of new targets for drug discovery and biomarkers for diagnostics. TIQUAS ...
Selcia Limited has launched a new platform that enables drug discovery and development on the target family of peptidyl-prolyl cis-trans isomerases (PPIases). The scope of the service includes drug screening, functional assays, compound ...
Tags: Selcia Limited, PPIases, drug screening, functional assays
PharmaInformatic has developed a comprehensive database on bioavailability to develop targeted new drugs. The new knowledge base, called PACT-F (Preclinical And Clinical Trials Knowledge Base on Bioavailability) combines the results ...
Nectid, a drug discovery company, has initiated clinical development of agomelatine for autism and pain indications in the US. Agomelatine, a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist, is approved for the ...
Afraxis and PsychoGenics have formed an alliance to provide Afraxis Enhanced Spine Platform (ESP) technology as part of PsychoGenics comprehensive testing capabilities and drug discovery services. The technology can evaluate as many as ...
Tags: ESP, PsychoGenics, Afraxis
Pharmaron has signed a multi-year agreement with AstraZeneca to accelerate drug discovery by supporting the Medicines Units. Pursuant to the agreement, Pharmaron will offer discovery services in the areas of chemistry, drug metabolism and ...
Tags: drug discovery, medicines, chemistry, drug metabolism, pharmacokinetics
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...